# AI& BLUEPRINT DOC ## Product Blueprint for a Physician-Controlled Clinical Assistance System Version 0.1 * March 2026 *** ## 1. Purpose AI& is a physician-controlled AI assistance system designed to reduce documentation burden, improve consistency of communication, and support evidence navigation in clinical workflows. AI& is not designed to replace physicians, make autonomous clinical decisions, diagnose patients independently, or communicate with patients without physician approval. The system is intended to support physicians by handling repetitive structure so that physicians can focus on clinical reasoning, empathy, and decision-making. *** ## 2. Product Vision AI& works behind the screen so physicians can remain fully present with patients. The product is built around four core ideas: 1. **Physician remains the decision-maker** 2. **AI assists structure, not judgment** 3. **Patient data must be handled with strict boundaries** 4. **Each physician agent is personalized without becoming uncontrollable** *** ## 3. Product Scope for Pilot Phase ### In Scope The first pilot version of AI& may include: * SOAP note draft generation from physician input * Structured clinical summary drafting * Discharge summary drafting * Evidence summarization from approved medical sources * Patient education draft generation * Follow-up reminder draft generation * Physician-controlled discussion prompts for anonymized case reflection ### Out of Scope The first pilot version must not include: * autonomous diagnosis * autonomous triage * medication prescribing * emergency decision-making * unsupervised patient messaging * direct patient-facing chatbot behavior * free-form cross-doctor sharing of raw patient data *** ## 4. Primary Users ### 4.1 Main User A licensed physician using AI& as a clinical assistance layer. ### 4.2 Secondary Users Depending on implementation maturity: * clinic administrator * nurse or assistant under role-based permissions * compliance or quality reviewer * technical operations team with limited non-clinical access ### 4.3 Non-Users in Pilot Patients do not directly operate AI& in the pilot stage. *** ## 5. Product Components AI& should be designed as a modular system. ### 5.1 Physician Workspace A secure interface used by the physician to: * enter structured clinical points * review AI-generated drafts * edit outputs * approve final content * view references and evidence links * review audit history ### 5.2 AI Draft Engine A controlled generation layer that transforms structured input into: * SOAP note drafts * visit summaries * education drafts * follow-up drafts This engine must operate only within predefined templates and approved workflows. ### 5.3 Evidence Layer A retrieval and summarization layer that: * searches approved sources * returns relevant references * summarizes guideline sections * links outputs to source material ### 5.4 Agent Profile Layer A physician-specific configuration layer that determines: * specialty * preferred documentation style * language tone * communication templates * preferred note structure * clinic workflow rules ### 5.5 Governance and Audit Layer A system layer responsible for: * access control * audit trails * approval logs * version history * data retention rules * safety monitoring *** ## 6. High-Level System Architecture The AI& system may be visualized in five layers: ### Layer 1 – Input Layer Receives physician input. Possible forms: * typed notes * structured forms * dictated notes * uploaded internal templates * checklist-based input ### Layer 2 – Processing Layer Prepares the input for safe structured generation. Functions: * de-identification where possible * field validation * template routing * context tagging * clinical workflow mapping ### Layer 3 – Intelligence Layer Produces assistance outputs. Functions: * structured draft generation * controlled summarization * evidence retrieval * template-aware text generation * follow-up checklist generation ### Layer 4 – Review Layer All AI outputs pass through physician review. Functions: * compare original input vs generated draft * edit output * approve or reject output * request regenerated version * record reasoning notes if needed ### Layer 5 – Logging and Governance Layer Records system behavior and enforces safety. Functions: * who accessed what * when output was generated * what was changed * who approved final version * whether patient-linked data was accessed * incident and anomaly logging *** ## 7. Clinical Data Flow AI& must handle clinical data with strict sequencing. ### Step 1 – Clinical Encounter or Documentation Trigger A physician completes or begins a patient encounter. ### Step 2 – Input to AI& The physician enters structured clinical points into AI&. Examples: * chief complaint * key findings * history highlights * assessment points * plan elements ### Step 3 – Input Classification The system classifies the request. Possible classes: * SOAP drafting * discharge summary * education note * follow-up plan * evidence request ### Step 4 – Minimum Necessary Context Assembly Only the minimum necessary context is passed into the AI task. This may include: * structured clinical facts * specialty context * physician template preferences * approved clinic communication rules ### Step 5 – AI Draft Generation The AI engine generates a draft output inside a constrained template. ### Step 6 – Physician Review The physician edits and approves the output. No AI output becomes final without human review. ### Step 7 – Finalization The approved version is either: * copied into the clinic documentation system * exported as a physician-approved draft * stored according to retention rules ### Step 8 – Logging The system stores metadata for traceability. *** ## 8. Clinical Data Boundaries AI& must follow the principle of **minimum necessary data use**. ### 8.1 Allowed Data in Pilot If needed and permitted by the implementation environment: * structured encounter notes * non-sensitive demographic basics * clinical observations relevant to documentation * physician-approved prompt context * internal templates and communication standards ### 8.2 Restricted Data The pilot should avoid or minimize use of: * unnecessary patient identifiers * full patient record ingestion by default * unrelated historical records * broad free-text uploads without review * open cross-doctor case sharing with identifiable details ### 8.3 Strongly Prohibited in Pilot The pilot must not allow: * unrestricted copy of the entire EMR into prompts * raw data sharing across physician agents * patient-identifiable data used for multi-doctor agent training without explicit governance * hidden use of patient data for general model retraining *** ## 9. Security and Privacy Boundaries The AI& system must be built as if clinical trust can shatter from one sloppy shortcut. ### 9.1 Access Control Access must be role-based. Examples: * physician can access own workspace and approved patient-linked tasks * admin can manage users but not view clinical content by default * technical team cannot access clinical text unless explicitly authorized and logged ### 9.2 Authentication Use strong authentication measures. Examples: * unique accounts per user * strong password policy * optional multi-factor authentication * session timeout ### 9.3 Encryption Clinical data should be protected: * in transit * at rest * during backup storage where applicable ### 9.4 Audit Logging The system must log: * logins * record access * AI generation events * edits * approvals * exports * unusual access behavior ### 9.5 Retention and Deletion The system must define: * what is stored * for how long * in what form * who can delete * what must be preserved for audit purposes ### 9.6 Data Segregation Data should be logically separated by: * clinic * physician * patient context * environment (production vs testing) *** ## 10. Safety Design Principles AI& should follow these product safety principles: ### 10.1 Human-in-the-Loop No final clinical artifact is released without physician review. ### 10.2 Constrained Generation Outputs are template-bounded wherever possible. ### 10.3 Source Visibility Evidence summaries should include source references. ### 10.4 No Silent Action The system should not send messages or finalize notes automatically. ### 10.5 Fall-back to Manual Workflow If the AI output is poor, unavailable, or uncertain, the physician must be able to continue manually without disruption. ### 10.6 Incident Handling The product must support internal reporting of: * misleading outputs * unsafe wording * missing information * access anomalies * privacy concerns *** ## 11. How AI& dr. A Differs from AI& dr. B This is a central design principle. AI& dr. A and AI& dr. B are not different medical authorities.\ They are different **configured physician workspaces**. Each agent may differ in: ### 11.1 Specialty Configuration Examples: * pediatrician * internist * dermatologist * general practitioner This affects: * note templates * evidence sources * terminology preferences * follow-up structures ### 11.2 Documentation Style Each physician may prefer: * short structured notes * more narrative assessments * specific SOAP layouts * clinic-specific terminology ### 11.3 Communication Style Each physician may define preferred tone: * highly formal * concise and direct * more empathetic for family-facing cases * bilingual or single-language preference ### 11.4 Workflow Rules Each physician may work with different routines: * follow-up schedule patterns * clinic operating procedures * referral patterns * visit summary standards ### 11.5 Permission Boundaries Each physician agent must remain isolated by default. AI& dr. A should not automatically access: * dr. B’s patient-linked drafts * dr. B’s private templates * dr. B’s review history Unless explicitly permitted and logged. *** ## 12. Personalization Without Unsafe Drift Personalization is useful, but must not become hidden model mutation. Therefore, physician personalization should rely on: * configuration files * template libraries * preference rules * prompt scaffolds * approved examples It should not rely on uncontrolled hidden retraining from raw patient cases. This allows AI& to remain: * explainable * governable * auditable * easier to validate *** ## 13. Cross-Agent Collaboration Model If AI& supports physician-to-physician collaboration, it should follow a structured model. ### Allowed Collaboration * anonymized case reflection * request for literature summary * request for template comparison * structured discussion prompts ### Restricted Collaboration * direct sharing of identifiable patient content * hidden transfer of patient-linked learning * autonomous AI-to-AI consultation that produces final clinical recommendations The system should treat collaboration as **physician-mediated discussion**, not machine-mediated authority. *** ## 14. Integration Strategy For pilot readiness, AI& may start as a sidecar system rather than a deeply embedded EMR replacement. ### Phase 1 – Standalone Secure Workspace Fastest to pilot. ### Phase 2 – Partial Integration Selective import/export with clinic systems. ### Phase 3 – Controlled Workflow Integration Deeper connection with documentation systems under governance approval. This staged approach reduces implementation risk. *** ## 15. Non-Functional Requirements The blueprint should include these operational expectations. ### Reliability The system must fail safely. ### Performance Draft generation should be fast enough for real clinical use. ### Usability Review and editing must be easier than writing from scratch. ### Traceability Every important action must be reconstructible. ### Maintainability Templates and safety rules must be easy to update. ### Scalability The architecture should support multiple physicians without data leakage across workspaces. *** ## 16. Pilot Success Metrics The pilot should measure practical outcomes. ### Efficiency Metrics * time saved per note * time saved per education draft * number of clicks or editing steps reduced ### Quality Metrics * physician-rated usefulness * physician-rated clarity * documentation consistency * source relevance for evidence summaries ### Safety Metrics * rate of misleading outputs * number of physician corrections * near-miss incidents * privacy/security incidents ### Adoption Metrics * percentage of eligible cases where AI& was used * repeat use by physicians * dropout reasons *** ## 17. Open Questions for Pilot Discussion These should be discussed with the doctors and team: 1. Which specialty is the safest and most useful starting point? 2. Which use case saves the most time without crossing into unsafe automation? 3. What patient data is truly necessary for the pilot? 4. What review rule is acceptable before any output is used? 5. What evidence sources are acceptable to the physicians? 6. Should the pilot start without patient identifiers? 7. What should be logged for legal, quality, and operational review? 8. What would make physicians trust or reject the system? *** ## 18. Recommended Pilot Positioning AI& should be introduced as: **A physician-controlled clinical documentation and communication assistant** Not as: * AI doctor * autonomous medical copilot * replacement for physician reasoning * automatic diagnostic engine This positioning is safer, more credible, and more aligned with healthcare governance expectations. *** ## 19. Final Principle AI& should make physicians more present, not more dependent. The system succeeds if it: * reduces friction * preserves judgment * protects privacy * improves consistency * keeps responsibility visible That is the foundation for building trust with doctors, clinics, and eventually patients. *** P.S. Other documents related to this document: * Document 1 – [Presentation Narrative](https://baca.endhonesa.com/all-notas-markdowns/~gitbook/pdf?page=E5VzjKUF9uWiZLSm2ccU\&only=yes\&limit=100) * Document 2 – [Strategic Notes and References](https://baca.endhonesa.com/all-notas-markdowns/~gitbook/pdf?page=0GGXb2ee133EHMKlaAEL\&only=yes\&limit=100) * Document 3 – [Product Blueprint](https://baca.endhonesa.com/all-notas-markdowns/~gitbook/pdf?page=FnTBSmfcfs4C6L0bUx6q\&only=yes\&limit=100) (this document) * Document 4 – [Pilot Protocol](https://baca.endhonesa.com/all-notas-markdowns/~gitbook/pdf?page=5asyed0eGqa2OH8eL8w3\&only=yes\&limit=100) * Document 5 – [Discussion Log](https://baca.endhonesa.com/all-notas-markdowns/~gitbook/pdf?page=vdfi50XnCdFLwdCRkk06\&only=yes\&limit=100) *** P.S.S. Read this document freely for information and guidance. Do not redistribute or restate—no quotes, summaries, paraphrases, or derivatives—without prior written permission from [**Prof. NOTA**](https://nota.endhonesa.com/). Sharing the link is allowed. So, share the link, not the text. Do not discuss or re-tell the contents in any form—written, spoken, or recorded—without prior written permission. ***